Literature DB >> 21762289

Neuropeptide Y signaling modulates the expression of ethanol-induced behavioral sensitization in mice.

Dayna M Hayes1, Jon R Fee, Thomas J McCown, Darin J Knapp, George R Breese, Inmaculada Cubero, Francisca Carvajal, Jose Manuel Lerma-Cabrera, Montserrat Navarro, Todd E Thiele.   

Abstract

Neuropeptide Y (NPY) and protein kinase A (PKA) have been implicated in neurobiological responses to ethanol. We have previously reported that mutant mice lacking normal production of the RIIβ subunit of PKA (RIIβ-/- mice) show enhanced sensitivity to the locomotor stimulant effects of ethanol and increased behavioral sensitization relative to littermate wild-type RIIβ+/+ mice. We now report that RIIβ-/- mice also show increased NPY immunoreactivity in the nucleus accumbens (NAc) core and the ventral striatum relative to RIIβ+/+ mice. These observations suggest that elevated NPY signaling in the NAc and/or striatum may contribute to the increased sensitivity to ethanol-induced behavioral sensitization that is a characteristic of RIIβ-/- mice. Consistently, NPY-/- mice failed to display ethanol-induced behavioral sensitization that was evident in littermate NPY+/+ mice. To examine more directly the role of NPY in the locomotor stimulant effects of ethanol, we infused a recombinant adeno-associated virus (rAAV) into the region of the NAc core of DBA/2J mice. The rAAV-fibronectin (FIB)-NPY(13-36) vector expresses and constitutively secretes the NPY fragment NPY(13-36) (a selective Y(2) receptor agonist) from infected cells in vivo. Mice treated with the rAAV-FIB-NPY(13-36) vector exhibited reduced expression of ethanol-induced behavioral sensitization compared with mice treated with a control vector. Taken together, the current data provide the first evidence that NPY signaling in the NAc core and the Y(2) receptor modulate ethanol-induced behavioral sensitization.
© 2011 The Authors, Addiction Biology © 2011 Society for the Study of Addiction.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21762289      PMCID: PMC3197888          DOI: 10.1111/j.1369-1600.2011.00336.x

Source DB:  PubMed          Journal:  Addict Biol        ISSN: 1355-6215            Impact factor:   4.280


  56 in total

1.  Deficits in amygdaloid cAMP-responsive element-binding protein signaling play a role in genetic predisposition to anxiety and alcoholism.

Authors:  Subhash C Pandey; Huaibo Zhang; Adip Roy; Tiejun Xu
Journal:  J Clin Invest       Date:  2005-10       Impact factor: 14.808

2.  Neuropeptide Y functions as a neuroproliferative factor.

Authors:  D E Hansel; B A Eipper; G V Ronnett
Journal:  Nature       Date:  2001-04-19       Impact factor: 49.962

3.  Modulation of [3H]Dopamine release from rat nucleus accumbens by neuropeptide Y may involve a sigma1-like receptor.

Authors:  D T Ault; J M Radeff; L L Werling
Journal:  J Pharmacol Exp Ther       Date:  1998-02       Impact factor: 4.030

4.  Comparison of basal neuropeptide Y and corticotropin releasing factor levels between the high ethanol drinking C57BL/6J and low ethanol drinking DBA/2J inbred mouse strains.

Authors:  Dayna M Hayes; Darin J Knapp; George R Breese; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2005-05       Impact factor: 3.455

5.  Involvement of the opioid system in the development and expression of sensitization to the locomotor-activating effect of ethanol.

Authors:  Rosana Camarini; Maria Laura Nogueira Pires; Helena Maria Calil
Journal:  Int J Neuropsychopharmacol       Date:  2000-12       Impact factor: 5.176

6.  Neuropeptide y and alcoholism: genetic, molecular, and pharmacological evidence.

Authors:  Subhash C Pandey; Lucinda G Carr; Markus Heilig; Erkki Ilveskoski; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2003-02       Impact factor: 3.455

7.  Adeno-associated virus-mediated expression and constitutive secretion of NPY or NPY13-36 suppresses seizure activity in vivo.

Authors:  S Foti; R P Haberman; R J Samulski; T J McCown
Journal:  Gene Ther       Date:  2007-08-23       Impact factor: 5.250

8.  Neuropeptide Y inhibits hippocampal seizures and wet dog shakes.

Authors:  D P Woldbye; T M Madsen; P J Larsen; J D Mikkelsen; T G Bolwig
Journal:  Brain Res       Date:  1996-10-21       Impact factor: 3.252

9.  Neuropeptide Y infusion into the shell region of the rat nucleus accumbens increases extracellular levels of dopamine.

Authors:  Gunnar Sørensen; Gregers Wegener; Jørgen Hasselstrøm; Thomas V O Hansen; Gitta Wörtwein; Anders Fink-Jensen; David P D Woldbye
Journal:  Neuroreport       Date:  2009-07-15       Impact factor: 1.837

10.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats.

Authors:  J T Clark; P S Kalra; W R Crowley; S P Kalra
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

View more
  5 in total

1.  Role of CA2+/calmodulin on ethanol neurobehavioral effects.

Authors:  Pablo Baliño; Juan Carlos Ledesma; Carlos M G Aragon
Journal:  Psychopharmacology (Berl)       Date:  2014-05-23       Impact factor: 4.530

2.  Histone acetylation in the nucleus accumbens shell modulates ethanol-induced locomotor activity in DBA/2J mice.

Authors:  Gretchen M Sprow; Jennifer A Rinker; Todd E Thiele
Journal:  Alcohol Clin Exp Res       Date:  2014-08-04       Impact factor: 3.455

Review 3.  Convergent functional genomics in addiction research - a translational approach to study candidate genes and gene networks.

Authors:  Rainer Spanagel
Journal:  In Silico Pharmacol       Date:  2013-12-13

Review 4.  Neuropeptide Y in Alcohol Addiction and Affective Disorders.

Authors:  Annika Thorsell; Aleksander A Mathé
Journal:  Front Endocrinol (Lausanne)       Date:  2017-07-31       Impact factor: 5.555

Review 5.  The Role of Neuropeptide Y in the Nucleus Accumbens.

Authors:  Masaki Tanaka; Shunji Yamada; Yoshihisa Watanabe
Journal:  Int J Mol Sci       Date:  2021-07-07       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.